SMI
11.791,91
PKT
-135,20
PKT
-1,13
%
Werbung
Analysen zu SMI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 23.10.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 22.10.19 | Roche buy | Deutsche Bank AG | |
| 22.10.19 | Novartis buy | Merrill Lynch & Co., Inc. | |
| 22.10.19 | UBS buy | Merrill Lynch & Co., Inc. | |
| 22.10.19 | Novartis buy | Jefferies & Company Inc. | |
| 22.10.19 | UBS Sector Perform | RBC Capital Markets | |
| 22.10.19 | Novartis Underweight | Morgan Stanley | |
| 22.10.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 22.10.19 | UBS overweight | JP Morgan Chase & Co. | |
| 22.10.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 22.10.19 | Novartis Neutral | UBS AG | |
| 22.10.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 22.10.19 | UBS Neutral | Goldman Sachs Group Inc. | |
| 22.10.19 | Novartis Hold | Deutsche Bank AG | |
| 21.10.19 | Roche buy | Goldman Sachs Group Inc. | |
| 21.10.19 | Novartis Underweight | Morgan Stanley | |
| 21.10.19 | Nestlé buy | Jefferies & Company Inc. | |
| 21.10.19 | Swiss Re Outperform | Credit Suisse Group | |
| 21.10.19 | Nestlé Hold | HSBC | |
| 21.10.19 | Roche overweight | JP Morgan Chase & Co. | |
| 18.10.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 18.10.19 | Nestlé Hold | HSBC | |
| 18.10.19 | Swiss Re Outperform | Credit Suisse Group | |
| 18.10.19 | Nestlé buy | Baader Bank | |
| 18.10.19 | UBS Outperform | Credit Suisse Group | |
| 18.10.19 | Nestlé buy | UBS AG | |
| 18.10.19 | Novartis Neutral | UBS AG | |
| 18.10.19 | Holcim overweight | JP Morgan Chase & Co. | |
| 17.10.19 | Roche overweight | Morgan Stanley | |
| 17.10.19 | UBS Neutral | JP Morgan Chase & Co. | |
| 17.10.19 | Roche Neutral | Credit Suisse Group | |
| 17.10.19 | Nestlé buy | Jefferies & Company Inc. | |
| 17.10.19 | Nestlé Underperform | RBC Capital Markets | |
| 17.10.19 | Nestlé market-perform | Bernstein Research | |
| 17.10.19 | Roche buy | Deutsche Bank AG | |
| 17.10.19 | Nestlé overweight | Morgan Stanley | |
| 17.10.19 | Roche overweight | Barclays Capital | |
| 17.10.19 | Nestlé buy | Goldman Sachs Group Inc. | |
| 17.10.19 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 17.10.19 | Novartis Underweight | JP Morgan Chase & Co. |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.